HROW

Harrow, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$28.3

Price (1 Year)

$54.18 $26.89

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %25.8 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments.

Website

Analysis (Turkish): HROW Hissesi Caiz mi, Helal mi? Harrow, Inc. Katılım Analizi